Evaluation of FIV protein-expressing VEE-replicon vaccine vectors in cats

By Burkhard M.J.   Valenski L.   Leavell S.   Dean G.A.   Tompkins W.A.F.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 258-268

Elsevier

Access to resources Recommend Favorite

Development of a rubella virus DNA vaccine

By Pougatcheva S.O.   Abernathy E.S.   Vzorov A.N.   Compans R.W.   Frey T.K.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 2104-2112

Elsevier

Access to resources Recommend Favorite

CVI awards celebrate the Year of the Vaccine and recent contributions in immunization and vaccine development

By Spier R.E.  

Vaccine, Vol. 15, Iss. 14, 1997-10 ,pp. : 1491-1493

Elsevier

Access to resources Recommend Favorite

Vaccine antigen production in transgenic plants: strategies, gene constructs and perspectives

By Sala F.   Manuela Rigano M.   Barbante A.   Basso B.   Walmsley A.M.   Castiglione S.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 803-808

Elsevier

Access to resources Recommend Favorite

Development of an AIDS vaccine: A daunting epidemiological challenge

By Nathanson Neal   Mathieson Bonnie  

European Journal of Epidemiology, Vol. 20, Iss. 2, 2005-02 ,pp. : 123-126

Springer Publishing Company

Access to resources Recommend Favorite